2-Bromo-α-Ergocryptine-d3

• Catalog No.: B682602
• M. F.: C32H40BrN5O5
• M. W.: 654.5945

SYNONYMS

• IUPAC name: (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^2,^6]dodecan-4-yl]-6-(^2H₃)methyl-6,11-diazatetracyclo[7.6.1.0^2,^7.0^1^2,^1^6]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
• IUPAC Traditional name: (4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-4-isopropyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^2,^6]dodecan-4-yl]-6-(^2H₃)methyl-6,11-diazatetracyclo[7.6.1.0^2,^7.0^1^2,^1^6]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide
• Synonyms: (5’α)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione-d3; Bagren-d3; 2-Bromoergocryptine-d3; Bromocriptine-d3; Bromocryptine-d3

DETAILS

Description (English)

Labelled 2-Bromo-α-Ergocryptine is a dopamine receptor agonist. 2-Bromo-α-Ergocryptine is a derivative of the ergotoxin group of ergot alkaloids. 2-Bromo-α-Ergocryptine is a prolactin inhibitor; antiparkinsonian.

REFERENCES

• Giron-Forest, D.A. et al.: Anal. Profiles Drug Subs., 8, 47 (1979)
• Camerman, N. et al.: Mol. Pharmacol., 19, 517 (1979)
• Ho, K.Y. et al.: Drugs, 36, 67 (1979)